Société de Néphrologie  by unknown
Relationship between anatomical alteration and distal tubule biochem-
ical variations in chromate-induced acute renal failure (ARF) in rat. C.
Orfila, J.M. Suc, J.P. Girolami, INSERM U /33, Faculté de Médecine
Ran gueil, 31062 Toulouse Cedex, France. Sodium chromate is a
nephrotoxicagent inducing ARF which is progressively reversible after
12 days (induced by a single sub-cutaneous injection, 20 mg/kg, to 24
Sprague-Dawley rats, 350 to 400 g). ARF was characterized by a
significant increase in diuresis and a glomerular filtration rate (OFR)
decrease. Urinary kallikrein excretion (UKI) strongly decreased and
Kal tissue content was significantly higher, suggesting accumulation of
Kal in tissue. Morphologically, the most important renal lesions con-
cerned proximal tubules which showed mitochondrial alterations, brush
border damage and the presence of numerous vesicles. Distal tubular
change was less marked; apical vacuoles and swollen mitochondria
were demonstrated. Using anti-rat Kal antibody, more intense immu-
nofluorescent positivity was present in distal tubule when compared to
controls. By immunoperoxydase Kal was observed in distal apical pole,
basolateral membranes, Golgi apparatus and vesicles. During the re-
versible phase GFR returned to normal values, and progressive recov-
ery of UKI toward control values was observed. These results demon-
strate that sodium chromate induces reversible renal failure. UKI
appears as a non-invasive and rapid method to assess the functional
integrity of the distal tubule.
Pachydermoperlostosis with proteinurla: A new cause of glomerular
hyperlIltration (GHF)? P. Bindi, A. Lagier, J. Erner. B. Mougenot. C.
Miche!, P. Ronco, F. Mignon, Hôpita! Tenon. 4. rue de Ia Chine, 75020
Paris and HOpit a! de Gonesse. 25. rue Pierre de Theilley, 95500
Gonesse, France. Pachydermoperiostosis (PDP) is a rare and often
inherited disease characterized by cutaneous hypertrophy of the face
and the limb extremities associated with periostitis of the distal bones.
Its etiology is unknown. We report the case of a 29-year-old West
Indian black man. POP had been diagnosed when he was 15. He
presented with a 2 g/day proteinuria without hematuria. Blood pressure
and physical examination were normal. There was no family history of
PDP or nephropathy. Inulin clearance and blood renal flow were
markedly increased in basal conditions (240 mI/mn and 1024 mI/mn,
respectively). There was no renal functional reserve as measured by the
method of amino acid infusion. Renal biopsy showed a mild mesangial
hypertrophy with capillary enlargement. Immunofluorescence was neg-
ative. Electron microscopy showed a thickening of the basement
membrane. Plasma growth factor levels were investigated after an oral
glucose charge: insulinemia, testosteronemia and growth hormone were
normal. The plasma level of lOF I was moderately reduced at 180 ng/ml
(normal range 302 58). Although the coexistence of two different
diseases may be fortuitous, we suggest that OHF played a role in the
development of proteinuria. OHF could be related to bone arterio-
veinous shunts responsible for an increased heart output. Both GHF
and PDP might be induced by a common growth factor yet unidentified.
Multivarlate analysisof the Influence of dialysis (D) and transplantation
(T) on the actuarial survival rate of end-stage renal disease (ESRD)
patients. E. A!amartine, G. Leroy, J. Tou!on, J. Jurine. C. Guerin, F.C.
Berthoux. Actuarial survival rate of 2% patients treated from 1973 to
1987 by D (158 cases). D and T (120 cases), or T (18 cases) has been
analyzed by: A) a simple comparison of these 3 previous groups; B) an
unbiased method which takes into account sequential risk following
successive modes of therapy. Univariate and multivanate (Cox's re-
gression) statistical analysis have bene used, including sex, age at
beginning of treatment (D = 51, D + T = 38, T = 42, P <. 106), primary
renal diagnosis: renal disease (D = 65%. D + T = 90%, T = 100%, P <
l0-) or systemic disease, and mode of therapy (D or/and T). Sixty-nine
patients died, and the overall survival rate was at 5, 10 and IS years
79%, 68% and 57%, respectively. For the groups D, D + T and T, it was
respectively 71%, 87% and 92% at +5 years (P < 0.01). These results
are explained by pre-treatment differences, whose influence on survival
rate is significant. Whatever the method (A or B) used to analyze the
influence of treatment, age at beginning (/3/sE = +5.61), and primary
renal diagnosis (/3/sE = +4.35) were successively the 2 factors which
influenced the survival rate. The unbiased method (B) also kept the
mode of therapy (/3/sE = + 1.75) as an independant and significant factor
of survival, and indicated a beneficient effect of transplantation versus
dialysis.
Renal biopsy in the elderly. A. Modesto-Segonds, M.F. Ah-Soune, D.
Durand, f.M. Suc, Service de Néphro!ogie, Laborazoire d'Immuno!o-
gie. C.H. U. Tou!ouse Rangueil. France. We reviewed the renal biopsy
findings of 314 patients who presented with renal discase after the age
of 65 years, between 1968 and 1988. A glomerular disease (ON) was
diagnosed in 203 patients (64.6%), three quarters of which was primary
renal disease and one quarter associated with systemic conditions.
Ninety patients (28.6%) presented tubulo-interstitial nephritis (TIN),
and in 21 patients (6.6%) prominent vascular disease was found. Their
incidence over 4 five-year periods shows a decline of TIN and an
increase of ON. The classification of the major GN diagnosed is the
following: membranous ON 18.7%, idiopathic crescentic ON and
vasculitis 17.7%, amyloidosis 10.8%. mesangiocapillary ON 9%, mini-
mal change 8.3%, Berger's disease (IgA) 8.3%, focal and segmental
proliferative ON 7%. diffuse mesangial proliferative ON 5.4%. diabetes
5.4%. Vascular fibrosis of variable intensity was a constant finding. In
66% of biopsies glomerulosclerosis impairing more than 10% of glomer-
uli was found, and 10% of biopsies showed diffuse glomerulosclerosis,
so-called age-related ischemic glomerulosclerosis. An outline of the
main clinical features was obtained for each renal disease: post-
streptococcal ON. crescentic ON, thrombotic microangiopathy, cho-
lesterol embolus nephropathy always presented as acute or rapidly
progressive renal failure. Ninety percent of minimal change, 90% of
membranous ON, and 85% of amyloidosis patients were nephrotic.
Eighty percent of the cases of diffuse glomerulosclcrosis and of the
cases of nephrosclerosis had proteinuria. Berger's disease was always
hematuric. We compared the incidences of the various ON diagnosed in
these elderly patients to those of an adult population (N = 273). The
most striking differences concern the following diseases: minimal
change 8.3% vs. 19.7% (<0.001): membranous ON. 18.7% vs. 9.5%
(<0.01); IgA, 8.3% vs. 22.7% (<0.001); crescentic ON and vasculitis,
17.7% vs. 5.4% (<0.001); amyloidosis, 10.8% vs. 1.4% (<0.001); lupus,
2.4% vs. 7.3% (<0.01); and diabetes, 5.4% vs. 1.4% (<0.01). It appears
that nephrotic syndrome is an important clinical condition in the
elderly. It might be steroid-sensitive in case of minimal change. Acute
or rapidly progressive renal failure is also a frequent presentation with
a high prevalence in those cases of crescentic ON and of vasculitis.
Nephrolithiasis revealing Sjogren's syndrome. P. Gobert, Ph. Van-
hi!!e, B. Mougenot, V. Lemaire. D. Fleurv, Services de Nephrologie
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Valenciennes et de Pathologie Paris Tenon, France. Metabolic acidosis
and high urinary pH (>5.5) are the main characteristics of distal renal
tubularacidosis (DRTA). Primary SjOgren syndrome (SS) is one of the
various autoimmune disorders which have been associated with DRTA,
This report concerns 3 cases of SS with nephrolithiasis and DRTA
without the clinical hallmarks of SS, i.e., the sicca complex. In 3
women with a mean age of 37 years, painful urologic manifestations
revealed the nephrolithiasis, with nephrocalcinosis in I case. Hypokali-
emic DRTA was associated with a deep hypocitraturia in 3/3 cases and
with hypercalciuria in only 1/3 cases; GFR was normal (1/3) or slightly
impaired (2/3). In 3/3 patients, the clinical symptoms of the sicca
complex were minimal or absent and the diagnosis of SS was estab-
lished by the following data: positivity of the Shirmer test and of
sequential salivary scintigraphy, a focal sialadenitis in labial salivary
gland biopsy specimens (grade IV Chisoim); and several immunologic
abnormalities: polyclonal hypergammaglobulinemia (3/3), autoantibod-
ies such as rheumatoid factor (3/3) and anti-SSA and SSB (3/3), type III
cryoglobulinemia (1/3). Renal biopsy showed a mononuclear cell inter-
stitial infiltrate without deposits of ig along the tubular basement
membrane and in the interstitium. These 3 cases emphasize the impor-
tance of urinary acidification in nephrolithiasis and of seeking SS in
every patient with unexplained DRTA. If alkali therapy is sufficient to
control the RTA, a steroid regimen may be added when highly cellular
interstitial nephritis is found.
Drug (D).induced acute renal failure (ARF): A preventable disease
linked to D misuse. D. Fleury, Ph. Vanhille, J.L. Pa/lot, D. Kleinknecht,
Services de Nephrologie, Valenciennes and Mont reuil-sous-Bois,
France. During a 4 year period, D-related ARF was recorded in 141
patients (pts) (male 60, female 81; mean age 58.9 18.1 years).
hospitalized in two nephrology units. D involved were primarily anti-
biotics (35), angiotensin converting enzyme inhibitors (ACEI) (31),
analgesics (30), non-steroidal anti-inflammatory drugs (NSAIDs) (22),
contrast media (14) and other D (9 pts). Sixty-eight pts had received
combined regimen with 2 to 6 different D. One hundred pts (71.4%) had
a non-oligunc course. According to clinical and pathological findings
(50 pts had a renal biopsy) acute tubular necrosis was diagnosed in 76
pts, pre-renal failure in 53, acute interstitial nephritis in 2, and other
types of ARF in 10 pts. Dialysis was required in 32 pts (22.7%). Nine pts
(6.4%) died, 102 recovered fully or regained previous renal function, 22
had permanent renal damage and 2 required chronic dialysis. Factors
predisposing to ARF were frequently found in 102 pts (mean age 66.1
years) receiving antibiotics, ACEI, NSAIDs and/or contrast media,
including sodium depletion (69.6%), pre-existing renal insufficiency
(24.5%), cardiac failure (19.6%), hypotension (10.8%) and hepatic
insufficiency (5.9%). Two or more predisposing factors were present in
73.5%, and a therapeutic error was obvious in 69.6% of these pts.
Compared to a previous series of D-related ARF (Néphrologie 7:41.
1986), these data show the increasing incidence of ARF due to ACE!
and/or NSAIDs, and the prominent role of D misuse in older pts with
multiple risk factors. They emphasize the importance of following the
recommended guidelines when D are prescribed in pts at high risk.
Recurrent thrombosis and renal vascular lesions (RVL) in patients with
a lupus anticoagulant (LA). D. Kleinknecht, G. Bobrie, P. Ca/lard, L.H.
Noel, M. Ramdane, Centre Hospitalier, Montreuil, Hôpital Necker,
Paris, and Hôpital Jean Verdier, Bondy, France. LA is often found in
patients (pts) with systemic lupus erythematosus (SLE), and is associ-
ated with an increased risk of thrombosis, including the kidney vessels.
We observed 5 pts (3F, 2M) with SLE, or with a lupus-like disease, in
whom LA was associated with recurrent venous thrombosis, including
pulmonary embolism in 2 cases and central nervous system involve-
ment in 3 cases. Three of three women had histories of spontaneous
abortions. All pts were hypertensive. 2 pts had renal insufficiency (RI),
2 non-nephrotic proteinuria; renal cortical ischemia was detected by a
CT-scan in I non-proteinuric pt. Renal biopsy showed in each Pt
thrombosis and/or intimal fibrosis of intrarenal vessels, and normal or
ischemic glomeruli. Four of five pts had low levels of anti-DNA
antibodies, 2/5 a positive VDRL, and 3/3 high titers of anticardiolipin
(ACL) antibodies. Four of five pts were thrombopenic. All pts received
antihypertensive drugs and steroid therapy, alone or with azathioprine
or anticoagulants; 2 had prolonged oral anticoagulation, but thrombotic
episodes recurred when the pts stopped the drug. High titers of ACL
antibodies persisted in I Pt despite the disappearance of LA. One pt
died; 4 survived 18 mo to 11 yrs after diagnosis, with stable chronic RI
in one. These results show that in some instances LA may be associated
with prominent RVL, in the absence of proliferative glomerular lesions.
If continuous anticoagulation may be beneficial in these pts, recurrence
of thromboembolic manifestations may promptly follow withdrawal of
therapy.
IgAdisease and carcinoma. Ph. Vanhille, E. Brevet, B. Mougenot, D.
Fleury, V. Lemaitre, P. Gobert, Services de Néphrologie, Valenciennes
et de Pat ho/ogie, Paris, Tenon, France. Since the report of Lee et al in
1966, the association of malignant tumors with glomerulonephritis (GN)
is well known, and it was found that most patients with carcinomas
have membranous ON. The aim of this study is to describe 6 patients
(pts) with carcinoma and IgA ON with or without the features of
Schoenlein-Henoch purpura (HSP). All pts were male with a mean age
of 59 years. The clinical diagnosis of malignancy and ON was simulta-
neous in 4 pts. In 2 pts, the carcinoma was not recognized until 6 and 17
months, respectively, after the onset of renal abnormalities. The
carcinoma was bronchogenic (4/6), esophageal (1/6) and pharyngeal
(1/6). At the time of renal biopsy, proteinuria and hematuria, macro-
scopic in I pt, were present in 6/6 pts and I Pt fulfilled the criteria for
nephrotic syndrome. Moderate renal impairment was found in 3 pts.
Three pts presented with symptoms suggestive of the HSP. Serum
cryoglobulinemia was not detected, but 5/6 pts had high levels of IgA
(>3.5 g/liter). Light microscopy showed mesangial proliferative (2/6),
focal and segmental (2/6), endo- and extracapillary (2/6) ON. All pts had
mesangial diffuse deposits of lgA, along with fibrinogen in 3/6 cases.
These observations suggest a causal relationship between the carci-
noma and IgA ON, with increased IgA production and subsequent IgA
mesangial deposits as a nonspecific response to chronic irritation of
mucosal membranes, afflicted by the neoplasia. The importance of
seeking malignancy should be considered in adults with IgA ON, at
least in old pts.
Binding of bradykinin (BK) in rat glomeruli: Some physiological and
pathological variabilities. J.L. Bascands, C. Emond, f.M. Suc, J.P.
Girolami. INSERM U 133, Facu/té de Médecine Rangueil, 3/062
Toulouse Cedex. France. Many pharmacological effects of BK (vasodi-
latation, natriuretic effect) have been reported. However, the mecha-
nism responsible for these effects remains unclear. To better specify
some effects of BK on renal glomerular hemodynamics we have
investigated the binding of BK in rat glomeruli. Incubation of BK,
labelled with 1251 with crude membrane preparation obtained from
isolated rat glomeruli revealed a specific binding with an equilibrium
dissociation constant (Kd) of 2.75 0.7 n and a density (Bmax) of 32.1
5.2 fmol/mg prot. In our studies ('251)-Tyr8-BK was reversed by BK,
but Des-Arg9-BK had no effect. These results are consistent with the
presence of a f32-kinin site in rat glomeruli. It is well known that changes
in sodium and water intake and the hypertensive state modulate the
activity of the renal kallikrein kinin system (RKKS). We thus have
examined the influence of these physiological and pathological states on
the glomerular /32-kinin sites. We observed a significant decrease in the
density of binding sites in the animals submitted to a low sodium diet
and also in the animals submitted to water deprivation, whereas the
RKKS activity was significantly increased. On the other hand, in
hypertensive rats the activity of the RKKS was decreased and the
density of binding sites was significantly increased. Our results show
that density of the glomerular /32-kinin binding sites is inversely related
to the activity of the RKKS. This suggests a homologous "down
regulation" of the giomerular 132-kinin binding sites.
Prevalence of symptomatic forms of adult polycystic kidney disease
(APKD). G. Cam, P. Simon, K.S. Ang, Department of Nephrology, La
Beauchée Hospital, Si Brieuc, 22000 France. The prevalence (P) of the
gene of APKD in a population has been evaluated to 1/1000 (Dalgaard,
1953). However, the clinical expression of the disease is variable in
each affected kindred, and sometimes among several affected members
in the same kindred. The aim of this study was to evaluate the P of
symptomatic APKD in a well defined area of 400,000 inhabitants. All
cases with APKD were followed in a single unit serving the area. Strong
collaboration was obtained with practitioners and urologists for this
investigation. One hundred and twenty-six pts from 54 kindred, alive at
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the time of investigation, were included: 34 either dialyzed or trans-
planted, 38 with CRF and 54 with normal renal function, among whom
some had hypertension. The table shows the P of symptomatic APKD
according to the age group in the population.
Age groups, years
20—39 40—59 60—79
P11000 0.22 0.70 0.51
Males 0.18 0.68 0.40
Females 0.26 0.71 0.58
These results show 1) diagnosis of APKD was done more often in F
than in M before 40 and after 60 yrs of age. 2) Asymptomatic or
unknown APKD would represent 30% to 50% of affected subjects after
40 yrs of age. Our study suggests: I) clinical expression of APKD could
be unknown or absent in a great number of subjects with APKD, but the
diagnosis of the disease would be done more often in F than in M; 2)
lifespan could be normal in many subjects with APKD.
Lifespan without end-stage renal disease (ESRD) in patients with adult
polycystic kidney disease (APKD). P. Simon, H.E. Thebaud and the
Collaborative Group of the Epidemiological Study of Renal Disease,
Britany and The Loire Valley, France. The aim of the study was to
evaluate the prognosis of APKD. A cohort of 1112 patients (pts) from
369 kindreds was assembled. Survival curves without ESRD and
without chronic renal failure (CRF) were estimated using a time-to-
event analysis (Kaplan-Meier). Comparisons were made with a Log
Rank test. Two hundred and twenty-three pts were excluded from the
study because information about age and/or renal function were missing
at the time of investigation. Of 889 pts who were included in the study,
297 were index cases (A) and 592 were other affected members (B).
Clinical situation of pts was the following: 438 were alive without
ESRD, 296 were hemodialyzed or transplanted or deceased due to renal
cause, and 155 were deceased for unknown cause. Distribution accord-
ing to sex (M:44.3%; F:55.7%) was similar in each group. Mean age
(yrs) was significantly higher in group A (53.2 14.1) than in group B
(46.7 17.1). Two possible bias were analyzed: 1) survival curve of
group A was not significantly different from that of group B; 2) the
influence of the group deceased for unknown cause on the survival
curve was not significant according to whether patients were censored
at the time of death (high hypothesis) or they were considered as
deceased for renal cause (low hypothesis). Therefore, survival curve
without ESRD for 889 pts showed that: I) lifespan was 80% by 50, 55%
by 60 and 27% by 70; 2) no difference was observed between females
and males. Survival curve without CRF for 565 living pts showed a
more progressive outcome of the disease for females compared to
males: 37% vs. 64% by 50 and 19% vs. 41% by 70(P <0.01). This study
confirms that the prognosis of APKD is not as grim as previous studies
estimated and that in a great number of pts with APKD, lifespan could
be normal. It also suggests that the outcome of the disease would be
more progressive in females than in males.
